Maintenance Therapy with Daratumumab ± Pomalidomide Following Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: Results from a Phase 2 Trial

By
Oren Pasvolsky
Bruno Almeida Costa
Yosra M. Aljawai
Krina K. Patel
Qaiser Bashir
Dawen Sui
Samer A. Srour
Mark R. Tanner
Uday R. Popat
Neeraj Y. Saini
Chitra Hosing
Jeremy L. Ramdial
Hans C. Lee
Gregory P. Kaufman
Sheeba K. Thomas
Donna M. Weber
Melody Becnel
Guilin Tang
Robert Z. Orlowski
Richard E. Champlin
Yago Nieto
Elizabeth J. Shpall
Muzaffar H. Qazilbash
September 26, 2026

Blood Cancer Journal

Original Source(s)

Blood Cancer Journal

Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study

by Oren Pasvolsky, Bruno Almeida Costa, Yosra M. Aljawai, Krina K. Patel, Qaiser Bashir, Dawen Sui, Samer A. Srour, Mark R. Tanner, Uday R. Popat, Neeraj Y. Saini, Chitra Hosing, Jeremy L. Ramdial, Hans C. Lee, Gregory P. Kaufman, Sheeba K. Thomas, Donna M. Weber, Melody Becnel, Guilin Tang, Robert Z. Orlowski, Richard E. Champlin, Yago Nieto, Elizabeth J. Shpall, Muzaffar H. Qazilbash
September 26, 2026

Related Content

Journal Of Medical Internet Research

Safety-Oriented Benchmarking of Large Language Models in Risk-Based Management of Abnormal Cervical Screening Results: Scenario-Based Benchmark Study

by Ömer Osman Eroğlu, Cansın Eroğlu
September 22, 2026

European Radiology

Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI

Baptist Health South Florida

A New Era for Pancreatic Cancer: How Baptist Health Research Helped Get Us Here

Pancreatic adenocarcinoma, the most common form of pancreatic cancer, accounts for roughly 90 to 95 percent of cases. It's notoriously difficult to catch early, because symptoms often don't appear until the disease has already spread

by
September 24, 2026
11 min